HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sauerbrunn, B. J. L. Articles by Hübner, K. F. Search for Related Content PubMed PubMed Citation Articles by Sauerbrunn, B. J. L. Articles by Hübner, K. F.

Ga-67 Citrate Imaging in Tumors of the Genito-Urinary Tract: Report of Cooperative Study

Veterans Administration Hospital, Washington, D.C.
Oak Ridge Associated Universities, Oak Ridge, Tennessee

Correspondence: For reprints contact: Medical and Health Sciences Div., Oak Ridge Associated Universities, P.O. Box 117, Oak Ridge, TN 37830.

ABSTRACT

Whole-body imaging with Ga-67 citrate in 127 tumors of the genito-urinary tract has been evaluated by a cooperative group using a uniform protocol. Primary sites of tumor were not detectable by imaging, except for one bladder and one kidney tumor. Proven and apparent metastases yielded positive scans, however, in 51% of prostatic, 50% of bladder, 72% of kidney, and 53% of testicular neoplasms. In bladder and kidneys metastases, if bone sites are excluded, detection of soft tissue metastases was 61% and 75%, respectively. In embryonal-cell carcinoma of the testicle, 74% of metastatic foci were detected.